Skip to main content
. 2022 Nov 21;3(12):100848. doi: 10.1016/j.xcrm.2022.100848

Figure 1.

Figure 1

Overview of cohort and experimental schematic

Whole blood samples were collected from three cohorts: (1) pediatric healthy controls, (2) pediatric acute COVID-19 infection, and (3) multisystem inflammatory syndrome in children (MIS-C). Plasma collected from whole-blood samples was used in proteomic assays to quantify levels of protein and cell-free DNA. Isolated neutrophils were used in bulk RNA sequencing and NETosis assays. Patient samples were used in individual or multiple assays.

See also Figure S1 and Tables S1 and S2.